Hu Xiaoxun, Liu Jiping, Fu Shucai, Wei Yonghao, Hu Wei, Liu Yaling, You Jin, Zhang Min
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Feb;29(3):223-5.
To evaluate the efficacy of sublingual immunotherapy (SLIT) with Dermatophagoides farinae drops for allergic rhinitis (AR) of different symptom severity.
This retrospective analysis to receive SLIT treatment of 143 cases of patients with allergic rhinitis, according to the severity of disease symptoms divid- ed into two groups, moderate group (62 patients) and severe group (81 patients). Before SLIT and after SLIT for half year, 1 year and 1. 5-2.0 years, the TNSS, TMS and sign scores of patients with allergic rhinitis were evaluated.
The TNSS, TMS and sign scores had continuously improved significantly after SLIT for half year, 1 year and 1.5-2.0 years in two groups as compared with baseline (P < 0.05). Before SLIT, TNSS and sign scores of severe group had a significantly higher level than moderate group (Z = 10.40, 2.40, P < 0.05), while TMS of two groups had no significant differences (Z = 0.00, P > 0.05). Half year after SLIT treatment, in two groups for sign scores, there were significant differences (Z = 3.32, P < 0.05), and there were no significant differences for TNSS (Z = 1.58, P > 0.05) and TMS (Z = 0.37, P > 0.05). 1 and 1.5-2.0 years after SLIT, there were no significant differences in two groups for TNSS, TMS and sign scores (P > 0.05).
SLIT with Dermatophagoides farinae drops for 1.5-2.0 years is effective in the patients with allergic rhinitis of different symptom severity. And equivalent efficacy could be achieved for different symptom severity.
评估舌下含服粉尘螨滴剂免疫疗法(SLIT)治疗不同症状严重程度变应性鼻炎(AR)的疗效。
本回顾性分析纳入143例接受SLIT治疗的变应性鼻炎患者,根据疾病症状严重程度分为两组,中度组(62例患者)和重度组(81例患者)。在SLIT治疗前以及SLIT治疗半年后、1年和1.5 - 2.0年时,对变应性鼻炎患者的总鼻症状评分(TNSS)、鼻结膜炎生活质量问卷(TMS)评分及体征评分进行评估。
与基线相比,两组在SLIT治疗半年后、1年和1.5 - 2.0年时,TNSS、TMS及体征评分均持续显著改善(P < 0.05)。SLIT治疗前,重度组的TNSS及体征评分显著高于中度组(Z = 10.40, 2.40, P < 0.05),而两组的TMS评分无显著差异(Z = 0.00, P > 0.05)。SLIT治疗半年后,两组体征评分有显著差异(Z = 3.32, P < 0.05),而TNSS(Z = 1.58, P > 0.05)及TMS(Z = 0.37, P > 0.05)无显著差异。SLIT治疗1年和1.5 - 2.0年后,两组TNSS、TMS及体征评分均无显著差异(P > 0.05)。
舌下含服粉尘螨滴剂进行1.5 - 2.0年的免疫疗法对不同症状严重程度的变应性鼻炎患者有效,且不同症状严重程度可获得同等疗效。